SEC Form 4 · accession 0000791908-15-000089
XOMA Royalty Corp · XOMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul D Rubin
Officer — Sr. VP Clinical Dev. & CMO
Period of report
Jul 15, 2015
Accepted (ET)
Jul 17, 2015 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000791908
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Jul 15, 2015 | M | 5,000 | $3.04 | A | 127,345 | D | |
| Common SharesF1,F2 | Jul 15, 2015 | S | 5,000 | $4.5984 | D | 122,345 | D | |
| Common Shares | holding | — | — | — | 6,881 | I | by 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Share Option (right to buy)F1,F3 | $3.04 | Jul 15, 2015 | M | 5,000 | D | — | May 31, 2021 | Common Shares | 5,000 | 27,040 | D |
Explanation of responses
- F1This transaction was made pursuant to Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2014.
- F2This transaction was executed in multiple trades ranging at prices from $4.59 to $4.60. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Company or a security holder of the Company full information regarding the number of shares and prices at which the transactions were effected.
- F3Incentive Stock Option exercisable in conjunction with matching Non-Qualified Stock Option as to (a) 25% of the option shares upon the first anniversary of the date of grant, and (b) the remaining 75% of the option shares in thirty-six (36) equal and consecutive monthly installments beginning one year and one month after the date of grant.